Compliance-Guided Abdominal Wall Closure Strategy in Large Ventral Hernia Repair
Condition(s) studied
Investigational drug(s) / intervention(s)
Compliance-Guided Abdominal Wall Closure Decision Strategy: A predefined intraoperative decision strategy that uses standardized measurements of static respiratory system compliance (Cstat) during abdominal wall closure to support selection of closure technique, with a predefined physiological tolerance threshold based on the baseline measurement.
Study summary
People undergoing repair of large ventral hernias can develop breathing problems after surgery, especially around the time when the abdominal wall is closed. During closure, pressure inside the abdomen may increase and lung mechanics can worsen. This study will evaluate a structured intraoperative decision approach that uses standard anesthesia measurements of static respiratory system compliance at predefined timepoints to support the choice of abdominal wall closure technique. The main goal is to assess the rate of early postoperative respiratory failure within 72 hours after surgery.
Eligibility
Primary outcome measure(s)
- Incidence of postoperative respiratory failure within 72 hours — Within 72 hours after surgery
Percentage of participants who develop postoperative respiratory failure within 72 hours after surgery, defined as meeting ≥1 of the following criteria: * Reintubation for respiratory reasons; OR * Non-invasive ventilation (NIV) or high-flow nasal oxygen (HFNO) delivered for \>6 consecutive hours for respiratory reasons; OR * Escalation of respiratory support for respiratory reasons (e.g., increase in oxygen delivery device/flow/FiO₂ or ventilatory support level). Unit of measure / tool: % of participants (derived from routine clinical documentation: anesthesia record, PACU/ICU charts, respiratory therapy notes).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| LUX MED Hospital, Gdańsk | Gdansk | Poland | Recruiting |
More Swissmed Hospital trials in Poland
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07422441 on ClinicalTrials.gov ↗ ← All trials in Poland